Quadria invests in healthcare businesses in some of the fastest growing markets, characterised by a large demand-supply gap for affordable healthcare services and products. Our actions, therefore, have an impact on society and the way that people live their lives. We believe that addressing the environmental, social and governance (ESG) issues is not only just the right thing to do, but critical for sustainable, long term value creation. Responsible investing is vital to Quadria’s success and it has become an integral part of our investment approach.

Quadria Capital adheres to the Global Impact Investing Rating System and United Nation’s Principles for Responsible Investment. We believe that the goals of “doing good” and “doing well” are not just compatible but in fact mutually reinforcing. As a result, Quadria has integrated consideration of ESG impact into investment decisions and portfolio company management. Working closely with our portfolio companies, we help to identify and drive strategic initiatives that are uniquely impactful to the businesses.

Social Impact

Award: 2016 best for the World Funds

Quadria is among the 50 funds recognized globally and the only healthcare focussed fund on the list.
The award validates Quadria’s effort towards responsible investment and goals of “doing good” and “doing well”.

Social Impact









South and Southeast Asia is home to more than 2 billion people and accounts for over 55% of the world’s disease burden. As the region grows and becomes more urbanised, life style changes are driving the incidence of chronic diseases leading to an increase in demand for good quality healthcare facilities and products. However, with the government spending in the region significantly trailing the world average and an exponentially increasing population, there exists a huge demand-supply gap for healthcare services and infrastructure in the region.

The challenge of bringing high quality healthcare at affordable prices could not be more acute as is in Asia. With rapidly rising population, historical under-investment in the sector is creating tremendous pressure on the existing healthcare infrastructure. The challenge is further complicated by certain differentiated issues in Asia:

  • The nature of disease burden in Asia has significantly changed. No longer are infectious diseases, such as tuberculosis and cholera, as prevalent as they used to be. Chronic diseases, such as diabetes and heart disease, increasingly dominate just as in the West
  • Despite rising income levels and increasing affluence, per capita spend in healthcare lags significantly behind developed markets at an average of less than US$ 200 per capita (versus US$ 8,000 in the US)
  • Most importantly, over 75% of patients in Asia that access healthcare pay out of pocket

Our key challenge, therefore is to invest in businesses that increase “access” and “affordability” for those who need it the most. As a healthcare focussed investor in a highly underserved region, Quadria aims to make a positive, transformational impact to its portfolio companies and their local communities above and beyond significant financial returns. Quadria’s companies bring about frugal innovation in their business models to achieve the twin objectives of addressing the mass market and at affordable prices. By investing in large scalable businesses, Quadria aims to achieve sustainable social impact by ultimately improving the lives of communities where we invest.


To operate with the utmost integrity and publicly minded spirit

Foster growth and create enterprises of enduring value

Create strong, sustainable organisations that provide individuals with the opportunity to work, live well and connect with each other


At Quadria, we believe that sustainable businesses are built upon strong ESG principles and that is why we are committed to fostering ESG aspects throughout the investment process. This includes defining our material issues, proactively engaging with our stakeholders, leveraging the advantages of our business model, and fostering strong partnerships to better contribute as a responsible member of an increasingly complex and interconnected global system.

We know that our decisions can have enormous impacts on companies and communities, and believe that the inclusion of ESG considerations leads to better compliance and governance. As a result, we have worked to thoughtfully incorporate environmental, social, and governance (ESG) factors in our decision making and management process to achieve positive impact for all stakeholders:

Our goal is to become a leader in ESG management among investors in the region by building responsible companies and delivering meaningful, sustainable impact to the communities which we operate in. To ensure that we continue to be at the forefront of key developments and challenges in ESG management and impact, we have maintained a network of external partners, including non-governmental and non-profit organisations, to help us and our portfolio companies understand and address various ESG issues.

We engage with various Developmental Finance Institutions (DFIs), who are also LPs in the fund, on an on-going basis on various ESG matters during our investment process. They help getting external expertise and perspective and allow us to access risk areas during the entire investment lifecycle. We have also institutionalised a Limited Partners Advisory Sub-Committee to support and advise the fund on E&S matters.

Our external partners include the Asian Venture Philanthropy Network (AVPN) and the Global Impact Investing Ratings System (GIIRS). We actively participate in and contribute to knowledge sharing sessions and speaker panels. For example, we actively speak at conferences such as the AVPN Annual Conference on the topics of ESG management as well as impact investment and measurement.

As a leader in healthcare investing in Asia, we also work closely with GIIRS to help augment their impact measurement toolkits for healthcare companies in this part of the world. We are constantly in dialogue with GIIRS’ research teams to share insights and challenges Asian healthcare companies face on impact measurement and ESG compliance.